Koers Stemcell United Limited Australian S.E.
Aandelen
BP8
AU000000SCU9
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 14,35 mln. 9,22 mln. 8,68 mln. | Omzet 2023 | 339 217,77 205,07 | Marktkapitalisatie | 3,85 mln. 2,48 mln. 2,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -1,93 mln. -1,81 mln. | Nettowinst (verlies) 2023 | -4 mln. -2,57 mln. -2,42 mln. | EV/omzet 2022 | 1,07 x |
Nettoschuld 2022 | 627K 403K 379K | Nettoliquiditeiten 2023 | 511K 328K 309K | EV/omzet 2023 | 9.862 x |
K/w-verhouding 2022 |
-3,98
x | K/w-verhouding 2023 |
-0,72
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 35,24% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 30-03-23 |
Justyn Stedwell
SEC | Corporate Secretary | - | 11/04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 21-07-21 | |
Paul Stephenson
CHM | Chairman | 63 | 31-03-20 |
Yan Hua Huang
BRD | Director/Board Member | - | 27-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,10% | 42,07 mld. | |
+48,49% | 42,16 mld. | |
+4,43% | 39,77 mld. | |
-11,36% | 26,68 mld. | |
+5,67% | 24,68 mld. | |
-22,84% | 18,68 mld. | |
-0,20% | 12,11 mld. | |
+26,30% | 11,99 mld. | |
+6,91% | 11,06 mld. |